User:XyZAn/sandbox/XyZan's Cladogram project/Abbvie-Allergan

Acquisition history
The following is an illustration of the company's major mergers and acquisitions and historical predecessors (this is not a comprehensive list):


 * Abbvie (Spun of from Abbott Laboratories)
 * Pharmacyclics (Acq 2015)
 * Stemcentrx (Acq 2016)
 * Allergan, plc (Acq 2019)
 * Allergan, inc
 * MAP Pharmaceuticals Inc (Acq 2013)
 * Kythera Biopharmaceuticals (Acq 2015)
 * Actavis plc
 * Eden Biodesign
 * Watson Pharmaceuticals
 * Warner Chilcott Plc (Acq 2000)
 * Andrx Corporation (Acq 2006)
 * Procter & Gamble (Prescription drug div, Acq 2009)
 * Arrow Group (Acq 2009)
 * Specifar Pharmaceuticals S.A. (Acq 2011)
 * Ascent Pharmahealth Ltd (Acq 2012)
 * Actavis Group (Acq 2012)
 * Galen (Acq 2013)
 * Uteron Pharma, S.A. (Acq 2013)
 * Durata Therapeutics (Acq 2014)
 * Silom Medical Company (Acq 2014)
 * Forest Laboratories (Acq 2014)
 * Aptalis Pharma
 * Axcan Pharma
 * Eurand Pharmaceuticals
 * Furiex Pharmaceuticals Inc (Acq 2014)
 * Auden Mckenzie Holdings Limited (Acq 2015)
 * Oculeve, Inc (Acq 2015)
 * Naurex Inc (Acq 2015)
 * AqueSys (Acq 2015)
 * Northwood Medical Innovation Ltd (Acq 2015)
 * Topokine Therapeutics (Acq 2016)
 * Vitae Pharmaceuticals, Inc (Acq 2016)
 * Tobira Therapeutics (Acq 2016)
 * ForSight VISION5 (Acq 2016)
 * RetroSense Therapeutics (Acq 2016)
 * Akarna Therapeutics (Acq 2016)
 * Motus Therapeutics (Acq 2016)
 * Chase Pharmaceuticals (Acq 2016)
 * LifeCell (Acq 2016)
 * Zeltiq Aesthetics Inc. (Acq 2017)
 * Keller Medical, Inc (Acq 2017)
 * Repros Therapeutics (Acq 2017)
 * Envy Medical, Inc. (Acq 2019)
 * Mavupharma (Acq 2019)